Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical application 1.Dx exercise intolerance 1.1  VO 2 max   VO 2 AT 1.2 RER >1.2 (HRmax is not achieved) 1.3  breathing reserve < 20% (N=20-40%)

Similar presentations


Presentation on theme: "Clinical application 1.Dx exercise intolerance 1.1  VO 2 max   VO 2 AT 1.2 RER >1.2 (HRmax is not achieved) 1.3  breathing reserve < 20% (N=20-40%)"— Presentation transcript:

1 Clinical application 1.Dx exercise intolerance 1.1  VO 2 max   VO 2 AT 1.2 RER >1.2 (HRmax is not achieved) 1.3  breathing reserve < 20% (N=20-40%) 1.4  SaO 2 1.5 V E /VO 2 (ventilatory equivalent for oxygen) > 40 2.Dx exercise-induced bronchospasm (EIB) 3.Aerobic fitness evaluation

2 Research study Optimal level of physical activity in children and adolescent with chronic lung disease

3 Objectives To study the optimal level of physical activity in children and adolescents with CLD

4 Normal (n=18)CLD (n=18) Hx & PE PFT - Spirometry - Lung volumes - DLco Exercise stress test VO 2 at AT  correlate with physical activity Experimental design

5 Results - Chronic interstitial lung1 - Post lobectomy5 - Pulmonary hemosiderosis1 - Fibrotic lung3 - BPD2 - Asthma moderate persistent6 Chronic lung diseases:

6 Abnormal PFT Obstructive lung7 (FEV 1 80.0 + 12.9%pred) Restrictive lung7 (TLC 63.7 + 12.5%pred) Diffusion defect1 (DLco/VA = 77 %pred) Hyperinflation9 (RV/TLC 38.9 + 6.5%pred)

7 CLD (n = 18) Control (n = 18) P FVC 77.3 + 22.697.9 + 12.5 0.002 FEV 1 74.3 + 17.6104.0 + 12.6 < 0.001 FEV 1 /FVC 83.4 + 12.790.1 + 3.8 0.047 FEF 25-75% 49.9 + 23.175.6 + 18.6 0.001 TLC 82.8 + 18.695.6 + 9.8 0.015 RV/TLC 30.8 + 10.224.4 + 5.9 0.027 DLco/VA 113.2 + 27.3109.1 + 30.3 0.671


Download ppt "Clinical application 1.Dx exercise intolerance 1.1  VO 2 max   VO 2 AT 1.2 RER >1.2 (HRmax is not achieved) 1.3  breathing reserve < 20% (N=20-40%)"

Similar presentations


Ads by Google